LFMD
LifeMD, Inc.
Company overview
- Market capitalization
- $141.23M
- Employees
- 347
- Latest publication
- 2026-09-29
About LifeMD, Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q4 20192019-12-31 · USD | Q3 20192019-09-30 · USD | Q2 20192019-06-30 · USD | Q1 20192019-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 47,281,085USD | 62,218,185USD | 65,697,756USD | 64,254,572USD | 3,944,454USD | 3,126,727USD | 2,698,407USD | 2,698,990USD |
| Cost Of Revenue | 5,284,323USD | 7,430,904USD | 8,643,716USD | 9,429,846USD | 512,043USD | 680,081USD | 655,211USD | 677,973USD |
| Gross Profit | 41,996,762USD | 54,787,281USD | 57,054,040USD | 54,824,726USD | 3,432,411USD | 2,446,646USD | 2,043,196USD | 2,021,017USD |
| Selling And Marketing Expenses | 28,035,947USD | 29,125,097USD | 29,194,061USD | 25,855,545USD | 3,335,941USD | 2,068,017USD | 1,815,082USD | 1,691,812USD |
| General And Administrative Expenses | 13,645,809USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 49,126,363USD | 55,694,053USD | 54,511,116USD | 53,806,484USD | 3,951,779USD | 3,420,352USD | 2,876,361USD | 2,584,386USD |
| Operating Income | -7,129,601USD | -906,772USD | 2,542,924USD | 1,018,242USD | -519,368USD | -973,706USD | -833,165USD | -563,369USD |
| Total Other Income Expense Net | 45,660USD | -663,027USD | -626,275USD | -614,074USD | -330,194USD | -130,936USD | -129,828USD | -170,194USD |
| Interest Expense | -45,660USD | 663,027USD | 626,275USD | 614,074USD | 330,194USD | 130,936USD | 129,826USD | 170,194USD |
| Income Before Tax | -7,083,941USD | -1,569,799USD | 1,916,649USD | 404,168USD | -849,562USD | -1,104,642USD | -962,991USD | -733,563USD |
| Income Tax Expense | 0USD | — | — | 169,477USD | -122,500USD | -160,838USD | -144,887USD | -124,700USD |
| Net Income | -7,083,941USD | -2,074,874USD | 1,384,804USD | -106,272USD | -711,547USD | -943,804USD | -818,104USD | -663,747USD |
| Net Income Applicable To Common Shares | -7,860,503USD | — | — | — | -711,547USD | — | — | — |
| Research Development | — | 2,744,272USD | 2,675,134USD | 2,410,653USD | 65,141USD | 61,221USD | 50,838USD | 45,738USD |
| Selling General Administrative | — | 17,565,187USD | 17,055,669USD | 19,909,060USD | 364,684USD | 1,352,335USD | 1,061,279USD | 892,574USD |
| Unclassified Operating Expenses | — | 6,259,497USD | 5,586,252USD | 5,631,226USD | — | — | — | — |
| Net Interest Income | — | -663,027USD | -626,275USD | -614,074USD | -330,194USD | — | — | — |
| Net Income From Continuing Ops | — | -1,569,799USD | 1,916,649USD | 234,691USD | -727,062USD | — | — | — |
| Ebit | — | -906,772USD | 2,542,924USD | 1,018,242USD | -519,368USD | -973,706USD | -833,163USD | -563,369USD |
| Ebitda | — | 1,916,328USD | 5,200,054USD | 3,565,337USD | -435,464USD | -889,804USD | -749,259USD | -479,466USD |
| Depreciation And Amortization | — | 2,823,100USD | 2,657,130USD | 2,547,095USD | 83,904USD | 83,902USD | 83,904USD | 83,903USD |
| Reconciled Depreciation | — | 2,823,100USD | 2,657,130USD | 2,547,095USD | 83,904USD | 83,902USD | 83,904USD | 153,884USD |
| Minority Interest | — | -505,075USD | -531,845USD | -340,963USD | -141,056USD | — | — | — |
| Tax Provision | — | — | 0USD | 169,477USD | -122,500USD | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD | FY 20112011-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 1,218,862USD | 714,158USD | 808,363USD | 673,778USD | 743,828USD |
| Cost Of Revenue | 247,772USD | 172,850USD | 181,304USD | 125,619USD | 241,264USD |
| Gross Profit | 971,090USD | 541,308USD | 627,059USD | 548,159USD | 502,564USD |
| Research Development | 23,925USD | — | — | — | — |
| Selling General Administrative | 978,721USD | 1,014,939USD | 1,173,467USD | 1,088,184USD | 1,078,931USD |
| Selling And Marketing Expenses | 230,661USD | 57,248USD | — | — | — |
| Total Operating Expenses | 1,233,307USD | 1,072,187USD | 1,173,467USD | 1,088,184USD | 1,078,931USD |
| Operating Income | -262,217USD | -530,879USD | -546,408USD | -540,025USD | -576,367USD |
| Interest Expense | 37,476USD | 4,683USD | 3,385USD | 3,371USD | 21,262USD |
| Income Before Tax | -172,432USD | -477,685USD | -285,462USD | -462,849USD | -520,129USD |
| Income Tax Expense | -13,200USD | -17,200USD | -17,200USD | -17,200USD | -17,200USD |
| Net Income | -61,992USD | -460,485USD | -268,262USD | -445,649USD | -502,929USD |
| Ebit | -134,957USD | -472,999USD | -282,078USD | -459,475USD | -498,867USD |
| Ebitda | -91,209USD | -416,024USD | -225,104USD | -402,501USD | -442,178USD |
| Depreciation And Amortization | 43,748USD | 56,975USD | 56,974USD | 56,974USD | 56,689USD |
| Total Other Income Expense Net | 89,785USD | 53,194USD | 260,946USD | 77,176USD | 56,238USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 59,892,898USD | 70,124,668USD | 70,411,319USD | 65,983,378USD | 73,564,702USD | 73,614,333USD | 72,460,026USD | 72,559,922USD |
| Total Current Assets | 42,084,479USD | 51,697,046USD | 51,831,465USD | 41,085,605USD | 49,025,763USD | 49,972,921USD | 48,733,089USD | 48,656,957USD |
| Other Current Assets | 2,486,803USD | 4,186,656USD | 2,966,294USD | 4,623,131USD | 2,215,974USD | 2,419,040USD | 2,712,994USD | 2,374,760USD |
| Total Liabilities | 51,926,443USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 46,608,830USD | 49,585,750USD | 41,573,365USD | 56,663,553USD | 63,532,158USD | 60,901,560USD | 60,255,145USD | 58,952,281USD |
| Other Current Liabilities | 16,961,186USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 7,966,455USD | 15,036,846USD | 23,156,580USD | 1,314,334USD | -1,782,554USD | -2,328,732USD | -5,485,501USD | -7,720,122USD |
| Total Equity Including Noncontrolling Interest | 7,966,455USD | — | — | — | — | — | — | — |
| Deferred Revenue | 10,791,221USD | — | — | — | — | — | — | — |
| Net Receivables | 11,256,158USD | 9,855,117USD | 9,305,277USD | 9,244,321USD | 7,330,129USD | 10,192,774USD | 8,217,813USD | 6,049,501USD |
| Inventory | 2,956,144USD | 3,177,136USD | 2,773,576USD | 3,432,382USD | 3,251,355USD | 2,967,697USD | 2,797,358USD | 2,645,443USD |
| Property Plant Equipment Net | 6,875,433USD | 5,055,090USD | 5,267,857USD | 5,578,992USD | 7,873,225USD | 7,543,692USD | 7,879,780USD | 6,750,256USD |
| Accounts Payable | 18,156,912USD | 21,653,122USD | 14,149,154USD | 19,554,735USD | 24,292,870USD | 15,679,028USD | 16,009,484USD | 15,867,469USD |
| Short Term Debt | 699,511USD | 670,825USD | 642,422USD | 673,482USD | 12,502,765USD | 12,093,250USD | 8,952,981USD | 5,681,097USD |
| Common Stock | 479,235USD | 476,327USD | 467,600USD | 466,864USD | 451,412USD | 436,327USD | 422,939USD | 419,096USD |
| Retained Earnings | -246,112,737USD | -238,252,234USD | -228,603,075USD | -247,790,178USD | -238,496,413USD | -235,644,977USD | -236,253,218USD | -235,370,384USD |
| Intangible Assets | — | 230,417USD | 262,334USD | 1,558,318USD | 16,665,714USD | 16,097,720USD | 15,847,157USD | 2,275,225USD |
| Total Liab | — | 55,087,822USD | 47,254,739USD | 62,615,226USD | 73,182,322USD | 74,007,087USD | 76,505,394USD | 78,514,986USD |
| Other Current Liab | — | 15,244,963USD | 15,974,016USD | 20,612,358USD | 12,679,052USD | 16,235,933USD | 18,544,316USD | 18,745,727USD |
| Capital Stock | — | 476,467USD | 467,740USD | 467,004USD | 451,552USD | 436,467USD | 423,079USD | 419,236USD |
| Cash | — | 34,478,137USD | 36,786,318USD | 23,785,771USD | 36,228,305USD | 34,393,410USD | 35,004,924USD | 37,587,253USD |
| Cash And Short Term Investments | — | 34,478,137USD | 36,786,318USD | 23,785,771USD | 36,228,305USD | 34,393,410USD | 35,004,924USD | 37,587,253USD |
| Current Deferred Revenue | — | 12,016,840USD | 10,807,773USD | 14,355,531USD | 11,790,024USD | 14,625,902USD | 14,480,917USD | 16,390,541USD |
| Net Debt | — | -28,305,240USD | -30,462,522USD | -17,260,616USD | -14,175,376USD | -9,294,633USD | -9,901,694USD | -12,443,451USD |
| Short Long Term Debt Total | — | 6,172,897USD | 6,323,796USD | 6,525,155USD | 22,052,929USD | 25,098,777USD | 25,103,230USD | 25,143,802USD |
| Property Plant Equipment Gross | — | 9,312,811USD | 9,420,400USD | 8,163,821USD | 7,873,225USD | 7,543,692USD | 7,879,780USD | 8,170,308USD |
| Accumulated Other Comprehensive Income | — | 0USD | 0USD | — | — | — | — | -140USD |
| Common Stock Shares Outstanding | — | 47,336,060shares | 46,773,743shares | 46,162,625shares | 44,401,531shares | 45,580,311shares | 42,205,767shares | 42,020,965shares |
| Non Current Assets Total | — | 18,427,622USD | 18,579,854USD | 24,897,773USD | 24,538,939USD | 23,641,412USD | 23,726,937USD | 23,902,965USD |
| Non Current Liabilities Total | — | 5,502,072USD | 5,681,373USD | 5,951,673USD | 9,650,164USD | 13,105,527USD | 16,250,249USD | 19,562,705USD |
| Non Currrent Assets Other | — | 13,142,115USD | 13,049,663USD | 17,760,463USD | 16,888,264USD | — | 15,295,685USD | 14,877,484USD |
| Net Working Capital | — | 2,111,296USD | 10,258,100USD | -15,577,948USD | -14,506,395USD | -10,928,639USD | -11,522,056USD | -10,295,324USD |
| Unclassified Non Current Liabilities | — | 5,502,072USD | 5,681,373USD | 5,851,673USD | 6,032,847USD | 6,186,692USD | 6,265,192USD | 6,511,425USD |
| Unclassified Equity | — | 252,336,286USD | 250,824,315USD | 248,170,644USD | 235,810,895USD | 232,443,451USD | 229,921,699USD | 226,812,070USD |
| Non Current Liabilities Other | — | — | — | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD |
| Unclassified Current Liabilities | — | — | — | 1,467,447USD | -9,693,337USD | -9,343,664USD | -6,176,997USD | -3,010,331USD |
| Short Long Term Debt | — | — | — | — | 11,960,784USD | 11,611,111USD | 8,444,444USD | 5,277,778USD |
| Long Term Debt | — | — | — | — | 3,517,317USD | 6,818,835USD | 9,885,057USD | 12,951,280USD |
| Unclassified Non Current Assets | — | — | — | — | -16,888,264USD | — | -15,295,685USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 70,411,319USD | 72,460,026USD | 58,480,709USD | 25,665,853USD | 49,923,243USD | 13,402,991USD | 3,446,179USD | 2,616,135USD |
| Intangible Assets | 262,334USD | 15,847,157USD | 14,805,242USD | 12,672,046USD | 3,015,550USD | 715,823USD | 675,452USD | 1,011,065USD |
| Other Current Assets | 2,966,294USD | 2,712,994USD | 1,420,360USD | 814,287USD | 996,746USD | 971,641USD | 592,971USD | 303,308USD |
| Total Liab | 47,254,739USD | 76,505,394USD | 52,914,550USD | 32,971,356USD | 24,104,133USD | 14,224,755USD | 4,575,420USD | 1,796,397USD |
| Total Stockholder Equity | 23,156,580USD | -5,485,501USD | 3,505,372USD | -6,829,955USD | 26,850,855USD | 1,353,923USD | -988,185USD | 897,700USD |
| Other Current Liab | 15,974,016USD | 18,544,316USD | 11,436,459USD | 9,665,474USD | 9,595,605USD | 1,610,248USD | 162,578USD | 868,997USD |
| Common Stock | 467,600USD | 422,939USD | 383,586USD | 315,528USD | 307,045USD | 234,337USD | 106,807USD | 457,822USD |
| Capital Stock | 467,740USD | 423,079USD | 383,726USD | 4,881,490USD | 4,418,007USD | 3,890,159USD | 534,037USD | 457,822USD |
| Retained Earnings | -228,603,075USD | -236,253,218USD | -214,265,236USD | -190,562,994USD | -141,921,085USD | -80,151,905USD | -16,594,916USD | -12,140,670USD |
| Cash | 36,786,318USD | 35,004,924USD | 33,146,725USD | 3,958,957USD | 41,328,039USD | 9,179,075USD | 1,106,624USD | 180,093USD |
| Cash And Short Term Investments | 36,786,318USD | 35,004,924USD | 33,146,725USD | 3,958,957USD | 41,328,039USD | 9,179,075USD | 1,106,624USD | 180,093USD |
| Total Current Assets | 51,831,465USD | 48,733,089USD | 42,604,267USD | 11,311,357USD | 44,921,440USD | 12,412,731USD | 2,747,102USD | 1,605,070USD |
| Total Current Liabilities | 41,573,365USD | 60,255,145USD | 34,781,724USD | 31,374,151USD | 22,825,589USD | 13,932,433USD | 3,975,442USD | 1,192,397USD |
| Current Deferred Revenue | 10,807,773USD | 14,480,917USD | 8,828,598USD | 5,547,506USD | 1,499,880USD | 916,880USD | 109,552USD | 75,984USD |
| Net Debt | -30,462,522USD | -9,901,694USD | -14,214,372USD | 168,522USD | -39,478,605USD | -8,114,620USD | -261,912USD | 67,323USD |
| Short Term Debt | 642,422USD | 8,952,981USD | 930,777USD | 3,553,343USD | 670,890USD | 872,132USD | 814,734USD | 247,416USD |
| Short Long Term Debt Total | 6,323,796USD | 25,103,230USD | 18,932,353USD | 4,127,479USD | 1,849,434USD | 1,064,455USD | 844,712USD | 247,416USD |
| Net Receivables | 9,305,277USD | 8,217,813USD | 5,277,250USD | 2,834,750USD | 980,055USD | 997,757USD | 97,448USD | 99,053USD |
| Inventory | 2,773,576USD | 2,797,358USD | 2,759,932USD | 3,703,363USD | 1,616,600USD | 1,264,258USD | 950,059USD | 1,022,616USD |
| Accounts Payable | 14,149,154USD | 16,009,484USD | 11,084,855USD | 10,106,793USD | 9,059,214USD | 10,408,172USD | 2,998,130USD | 868,997USD |
| Property Plant Equipment Net | 5,267,857USD | 7,879,780USD | 1,071,200USD | 1,682,450USD | 1,986,253USD | 274,437USD | 23,625USD | — |
| Property Plant Equipment Gross | 9,420,400USD | 7,879,780USD | 1,071,200USD | 1,682,450USD | 1,986,253USD | 274,437USD | 23,625USD | — |
| Accumulated Other Comprehensive Income | 0USD | — | -140USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Common Stock Shares Outstanding | 45,129,617shares | 41,196,000shares | 33,905,155shares | 30,976,455shares | 27,007,961shares | 14,275,153shares | 9,897,745shares | 9,053,421shares |
| Non Current Assets Total | 18,579,854USD | 23,726,937USD | 15,876,442USD | 14,354,496USD | 5,001,803USD | 990,260USD | 699,077USD | 1,011,065USD |
| Non Current Liabilities Total | 5,681,373USD | 16,250,249USD | 18,132,826USD | 1,597,205USD | 1,278,544USD | 292,322USD | 599,978USD | 604,000USD |
| Non Currrent Assets Other | 13,049,663USD | 15,295,685,000,000USD | -1USD | -14,354,496USD | -5,001,803USD | -990,260USD | -699,077USD | — |
| Net Working Capital | 10,258,100USD | -11,522,056USD | 7,822,543USD | -20,062,794USD | 22,095,851USD | -1,426,701USD | -1,228,340USD | 412,673USD |
| Unclassified Non Current Liabilities | 5,681,373USD | 6,265,192USD | — | -1,023,069USD | 1,078,544USD | — | — | — |
| Unclassified Equity | 250,824,315USD | 229,921,699USD | 217,003,436USD | 178,699,722USD | 164,210,589USD | 77,545,033USD | 14,965,887USD | 12,122,726USD |
| Good Will | — | 2,030,640,152,843USD | — | — | — | — | — | — |
| Other Assets | — | -23,726,913,273,063USD | 1USD | — | — | — | — | — |
| Short Long Term Debt | — | 8,444,444USD | 327,597USD | 2,797,250USD | 63,400USD | 779,132USD | 814,734USD | 247,416USD |
| Long Term Debt | — | 9,885,057USD | 17,927,727USD | — | — | — | — | — |
| Non Current Liabilities Other | — | 100,000USD | 131,250USD | 1,597,205USD | 100,000USD | 100,000USD | 500,000USD | 600,000USD |
| Unclassified Non Current Assets | — | -17,326,325,152,843USD | — | — | — | — | — | — |
| Unclassified Current Liabilities | — | -6,176,997USD | 2,173,438USD | — | 1,936,600USD | — | — | -1,116,413USD |
| Other Liab | — | — | — | 1,023,069USD | 100,000USD | 100,000USD | 570,000USD | 604,000USD |
| Treasury Stock | — | — | — | -163,701USD | -163,701USD | -163,701USD | — | — |
| Net Tangible Assets | — | — | — | -19,502,141USD | 19,724,343USD | -3,017,722USD | -1,663,637USD | -113,365USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -8,872,596USD | 15,619,791USD | -4,670,027USD | -1,569,799USD | 1,916,649USD | 234,691USD | -5,477,232USD | -6,837,034USD |
| Depreciation | 1,996,227USD | 1,668,118USD | -4,470,523USD | -1,950,354USD | 2,657,130USD | 2,547,095USD | 2,556,917USD | 2,288,225USD |
| Stock Based Compensation | 1,448,905USD | 2,655,143USD | 3,198,036USD | 2,094,614USD | 2,548,528USD | 3,104,956USD | 2,394,235USD | 4,191,176USD |
| Other Non Cash Items | 1,661,672USD | -18,013,499USD | 6,254,413USD | 5,155,854USD | 396,177USD | 1,023,155USD | 238,084USD | 285,032USD |
| Change To Account Receivables | -549,840USD | -459,227USD | 722,079USD | 2,862,645USD | -1,974,961USD | -2,168,312USD | -381,559USD | -331,451USD |
| Change To Inventory | -403,560USD | 1,268,015USD | -181,027USD | -283,658USD | -170,339USD | -827,584USD | -584,724USD | 312,921USD |
| Change In Working Capital | 5,659,321USD | -5,210,076USD | -459,035USD | 4,909,132USD | -4,450,097USD | -5,341,548USD | 6,490,915USD | 4,612,364USD |
| Total Cash From Operating Activities | 444,624USD | -3,280,523USD | -147,136USD | 8,639,447USD | 3,068,387USD | 1,568,349USD | 6,202,919USD | 4,539,763USD |
| Capital Expenditures | -105,178USD | -155,457USD | 6,566,921USD | 2,867,338USD | -2,867,338USD | -2,720,727USD | -3,493,298USD | -3,132,028USD |
| Free Cash Flow | 339,446USD | -3,435,980USD | 6,419,785USD | 11,506,785USD | 201,049USD | -1,152,378USD | 2,709,621USD | 1,407,735USD |
| Total Cashflows From Investing Activities | -2,056,762USD | 17,069,632USD | -3,594,480USD | -3,699,583USD | -2,867,338USD | -2,720,727USD | -3,493,298USD | -3,132,028USD |
| Total Cash From Financing Activities | -696,043USD | -788,562USD | -8,700,918USD | -3,104,969USD | -812,563USD | -1,429,951USD | -825,583USD | -815,449USD |
| Dividends Paid | -776,563USD | -776,562USD | -776,563USD | -776,562USD | -776,563USD | -776,562USD | -776,563USD | -776,562USD |
| Change In Cash | -2,308,181USD | 13,000,547USD | -12,442,534USD | 1,834,895USD | -611,514USD | -2,582,329USD | 1,884,038USD | 592,286USD |
| Begin Period Cash Flow | 36,786,318USD | 23,785,771USD | 36,228,305USD | 34,393,410USD | 35,004,924USD | 37,587,253USD | 35,703,215USD | 35,110,929USD |
| End Period Cash Flow | 34,478,137USD | 36,786,318USD | 23,785,771USD | 36,228,305USD | 34,393,410USD | 35,004,924USD | 37,587,253USD | 35,703,215USD |
| Other Cashflows From Investing Activities | -1,951,584USD | 16,426,858USD | -4,512,436USD | -3,821,794USD | -2,745,127USD | -2,495,317USD | -3,045,496USD | -2,489,975USD |
| Other Cashflows From Financing Activities | 80,520USD | -12,000USD | -449,540USD | -276,119USD | -36,000USD | -665,888USD | -36,000USD | 64,000USD |
| Unclassified Operating Cash Flow | -1,448,905USD | — | — | — | — | — | — | — |
| Net Borrowings | — | 0USD | -16,667,433USD | -2,052,288USD | 0USD | 0USD | -13,020USD | — |
| Issuance Of Capital Stock | — | 0USD | — | — | — | 0USD | — | — |
| Investments | — | — | -3,594,480USD | -3,699,583USD | -2,867,338USD | -2,720,727USD | -3,493,298USD | -3,132,028USD |
| Unclassified Investing Cash Flow | — | — | -2,054,485USD | — | 5,612,465USD | 5,216,044USD | 6,538,794USD | 5,622,003USD |
| Unclassified Financing Cash Flow | — | — | 9,192,618USD | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 15,619,791USD | -18,728,498USD | -20,595,992USD | -45,021,027USD | -61,324,056USD | -60,524,351USD | -3,528,258USD | -1,360,089USD |
| Depreciation | 328,371USD | 9,491,522USD | 6,600,226USD | 3,770,234USD | 868,757USD | 397,765USD | 335,613USD | 195,775USD |
| Stock Based Compensation | 10,496,321USD | 12,234,797USD | 12,489,343USD | 13,734,614USD | 12,071,659USD | 18,656,141USD | 733,215USD | 273,570USD |
| Other Non Cash Items | -10,313,144USD | 1,867,168USD | 5,419,258USD | 5,776,067USD | 2,112,936USD | 19,626,796USD | 578,609USD | 237,200USD |
| Change To Account Receivables | 1,150,536USD | -2,940,563USD | -2,442,500USD | -2,192,888USD | 17,702USD | -550,973USD | 1,605USD | 29,137USD |
| Change To Inventory | 303,236USD | 675,669USD | 764,331USD | -2,183,012USD | -409,823USD | -314,199USD | 72,557USD | -341,358USD |
| Change In Working Capital | -7,851,164USD | 12,648,201USD | 4,907,397USD | -1,549,037USD | 9,132,175USD | 8,797,173USD | 2,066,229USD | -255,974USD |
| Total Cash From Operating Activities | 8,280,175USD | 17,513,190USD | 8,820,232USD | -22,935,149USD | -33,085,489USD | -12,131,614USD | 251,408USD | -905,518USD |
| Capital Expenditures | -9,518,627USD | -11,536,318USD | -8,733,284USD | -12,893,338USD | -3,402,289USD | -398,136USD | -247,365USD | -100,000USD |
| Free Cash Flow | -1,238,452USD | 5,976,872USD | 86,948USD | -35,828,487USD | -36,487,778USD | -12,529,750USD | 251,408USD | -1,005,518USD |
| Total Cashflows From Investing Activities | 6,908,231USD | -11,536,318USD | -8,733,284USD | -13,905,733USD | -3,402,289USD | -798,136USD | -100,000USD | 141,445USD |
| Net Borrowings | -18,719,721USD | -327,597USD | 16,672,036USD | 2,737,250USD | -530,819USD | 93,192USD | 798,279USD | 642,441USD |
| Total Cash From Financing Activities | -13,407,012USD | -4,118,673USD | 29,100,820USD | -528,200USD | 68,636,742USD | 21,002,201USD | 775,123USD | 802,787USD |
| Dividends Paid | -3,106,250USD | -3,106,250USD | -3,106,250USD | -3,106,250USD | -871,476USD | -1,289,657USD | -871,476USD | -871,476USD |
| Issuance Of Capital Stock | 8,721,717USD | 0USD | 899,567USD | 55,342,927USD | 69,331,678USD | 20,131,069USD | 349,999USD | 0USD |
| Change In Cash | 1,781,394USD | 1,858,199USD | 29,187,768USD | -37,369,082USD | 32,148,964USD | 8,072,451USD | 926,531USD | 38,714USD |
| Begin Period Cash Flow | 35,004,924USD | 33,146,725USD | 3,958,957USD | 41,328,039USD | 9,179,075USD | 1,106,624USD | 180,093USD | 141,379USD |
| End Period Cash Flow | 36,786,318USD | 35,004,924USD | 33,146,725USD | 3,958,957USD | 41,328,039USD | 9,179,075USD | 1,106,624USD | 180,093USD |
| Other Cashflows From Investing Activities | 8,778,899USD | -10,045,461USD | -8,529,470USD | -13,539,100USD | -3,154,924USD | -798,136USD | -100,000USD | 290,000USD |
| Other Cashflows From Financing Activities | -773,658USD | -684,826USD | -667,625USD | 2,746,800USD | -444,000USD | 6,262,440USD | -373,155USD | 160,346USD |
| Unclassified Investing Cash Flow | 7,647,959USD | 21,581,779USD | 16,817,130USD | 26,432,438USD | 6,557,213USD | 1,196,272USD | — | — |
| Investments | — | -11,536,318USD | -8,287,660USD | -13,905,733USD | -3,402,289USD | -798,136USD | -100,000USD | 141,445USD |
| Sale Purchase Of Stock | — | — | 36USD | -15,100USD | 72,458,251USD | 1,289,657USD | — | 0USD |
| Unclassified Financing Cash Flow | — | — | 16,202,623USD | -2,890,900USD | -1,975,214USD | 14,646,569USD | — | — |
| Change To Liabilities | — | — | — | 3,100,209USD | 9,549,401USD | 10,303,515USD | 2,215,727USD | 343,055USD |
| Cash And Cash Equivalents Changes | — | — | — | -37,369,082USD | 32,148,964USD | 8,072,451USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | 4,053,040USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Segment | Telehealth | 18,002,742 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Telehealth Subscription Revenue | 29,278,343 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Segment | Telehealth | 19,755,129 | USD | 0001493152-26-021536 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Telehealth Subscription Revenue | 30,407,827 | USD | 0001493152-26-021536 |
| FY 2025Yearly · 2025-12-31 | Segment | Telehealth | 80,786,095 | USD | 0001493152-26-009549 |
| FY 2025Yearly · 2025-12-31 | Segment | Telehealth Subscription Revenue | 113,269,103 | USD | 0001493152-26-009549 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Telehealth | 19,979,502 | USD | 0001493152-25-023906 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Telehealth Subscription Revenue | 27,300,431 | USD | 0001493152-25-023906 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Work Simpli | 12,892,537 | USD | 0001493152-25-023906 |
| Q3 2025Quarterly · 2025-09-30 | Product | Telehealth Revenue | 47,279,933 | USD | 0001493152-25-023906 |
| Q3 2025Quarterly · 2025-09-30 | Product | Work Simpli Revenue | 12,892,537 | USD | 0001493152-25-023906 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Telehealth | 19,392,851 | USD | 0001641172-25-022272 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Telehealth Subscription Revenue | 29,170,821 | USD | 0001641172-25-022272 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Work Simpli | 13,654,513 | USD | 0001641172-25-022272 |
| Q2 2025Quarterly · 2025-06-30 | Product | Telehealth Revenue | 48,563,672 | USD | 0001641172-25-022272 |
| Q2 2025Quarterly · 2025-06-30 | Product | Work Simpli Revenue | 13,654,513 | USD | 0001641172-25-022272 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Telehealth | 20,760,363 | USD | 0001493152-26-021536 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Telehealth Subscription Revenue | 30,127,536 | USD | 0001493152-26-021536 |
| Q1 2025Quarterly · 2025-03-31 | Product | Telehealth Revenue | 52,456,481 | USD | 0001641172-25-008864 |
| Q1 2025Quarterly · 2025-03-31 | Product | Work Simpli Revenue | 13,241,275 | USD | 0001641172-25-008864 |
| FY 2024Yearly · 2024-12-31 | Segment | Medifast Collaboration Revenue | 5,000,000 | USD | 0001493152-26-009549 |
| FY 2024Yearly · 2024-12-31 | Segment | Telehealth | 82,139,528 | USD | 0001493152-26-009549 |
| FY 2024Yearly · 2024-12-31 | Segment | Telehealth Subscription Revenue | 67,684,547 | USD | 0001493152-26-009549 |
| Q4 2024Quarterly · 2024-12-31 | Product | Telehealth Revenue | 50,010,237 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Work Simpli Revenue | 14,365,198 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Telehealth Revenue | 158,438,631 | USD | 0001493152-25-009790 |
| FY 2024Yearly · 2024-12-31 | Product | Work Simpli Revenue | 54,015,207 | USD | 0001493152-25-009790 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Telehealth | 19,225,172 | USD | 0001493152-25-023906 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Telehealth Subscription Revenue | 20,929,511 | USD | 0001493152-25-023906 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Work Simpli | 13,117,611 | USD | 0001493152-25-023906 |
| Q3 2024Quarterly · 2024-09-30 | Product | Telehealth Revenue | 40,154,683 | USD | 0001493152-25-023906 |
| Q3 2024Quarterly · 2024-09-30 | Product | Work Simpli Revenue | 13,117,611 | USD | 0001493152-25-023906 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Medifast Collaboration Revenue | 3,031,250 | USD | 0001641172-25-022272 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Telehealth | 20,519,165 | USD | 0001641172-25-022272 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Telehealth Subscription Revenue | 13,881,894 | USD | 0001641172-25-022272 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Work Simpli | 13,229,536 | USD | 0001641172-25-022272 |
| Q2 2024Quarterly · 2024-06-30 | Product | Telehealth Revenue | 37,432,309 | USD | 0001641172-25-022272 |
| Q2 2024Quarterly · 2024-06-30 | Product | Work Simpli Revenue | 13,229,536 | USD | 0001641172-25-022272 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Medifast Collaboration Revenue | 1,968,750 | USD | 0001641172-25-008864 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Telehealth | 21,264,864 | USD | 0001641172-25-008864 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Telehealth Subscription Revenue | 7,607,788 | USD | 0001641172-25-008864 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Work Simpli | 13,302,862 | USD | 0001641172-25-008864 |
| Q1 2024Quarterly · 2024-03-31 | Product | Telehealth Revenue | 30,841,402 | USD | 0001641172-25-008864 |
| Q1 2024Quarterly · 2024-03-31 | Product | Work Simpli Revenue | 13,302,862 | USD | 0001641172-25-008864 |
| FY 2023Yearly · 2023-12-31 | Segment | Medifast Collaboration Revenue | 5,000,000 | USD | 0001493152-25-009790 |
| FY 2023Yearly · 2023-12-31 | Segment | Telehealth | 88,886,664 | USD | 0001493152-25-009790 |
| FY 2023Yearly · 2023-12-31 | Segment | Telehealth Subscription Revenue | 4,266,255 | USD | 0001493152-25-009790 |
| FY 2023Yearly · 2023-12-31 | Segment | Work Simpli | 54,394,087 | USD | 0001493152-25-009790 |
| Q4 2023Quarterly · 2023-12-31 | Product | Telehealth Revenue | 31,256,199 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Product | Work Simpli Revenue | 13,603,648 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Product | Telehealth Revenue | 98,152,919 | USD | 0001493152-25-009790 |
| FY 2023Yearly · 2023-12-31 | Product | Work Simpli Revenue | 54,394,087 | USD | 0001493152-25-009790 |
| FY 2022Yearly · 2022-12-31 | Segment | Telehealth | 82,649,845 | USD | 0001493152-24-009581 |
| FY 2022Yearly · 2022-12-31 | Segment | Work Simpli | 36,383,675 | USD | 0001493152-24-009581 |
| FY 2022Yearly · 2022-12-31 | Product | Telehealth Revenue | 82,649,845 | USD | 0001493152-24-009581 |
| FY 2022Yearly · 2022-12-31 | Product | Work Simpli Revenue | 36,383,675 | USD | 0001493152-24-009581 |
| FY 2021Yearly · 2021-12-31 | Segment | Telehealth | 68,197,128 | USD | 0001493152-23-008560 |
| FY 2021Yearly · 2021-12-31 | Segment | Work Simpli | 24,678,678 | USD | 0001493152-23-008560 |
| FY 2021Yearly · 2021-12-31 | Product | Telehealth Revenue | 68,197,128 | USD | 0001493152-23-008560 |
| FY 2021Yearly · 2021-12-31 | Product | Work Simpli Revenue | 24,678,678 | USD | 0001493152-23-008560 |
| FY 2020Yearly · 2020-12-31 | Segment | Telehealth | 30,561,163 | USD | 0001493152-22-006182 |
| FY 2020Yearly · 2020-12-31 | Segment | Worksimpli | 6,732,747 | USD | 0001493152-22-006182 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 30,556,163 | USD | 0001493152-21-007194 |
| FY 2020Yearly · 2020-12-31 | Product | Software Revenue — Services | 5,000 | USD | 0001493152-21-007194 |
| FY 2020Yearly · 2020-12-31 | Product | Software Revenues Net | 6,732,747 | USD | 0001493152-21-007194 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 9,919,506 | USD | 0001493152-21-007194 |
| FY 2019Yearly · 2019-12-31 | Product | Software Revenue — Services | 9,943 | USD | 0001493152-21-007194 |
| FY 2019Yearly · 2019-12-31 | Product | Software Revenues Net | 2,539,129 | USD | 0001493152-21-007194 |
| FY 2018Yearly · 2018-12-31 | Product | Product Revenues Net | 8,044,416 | USD | 0001493152-20-005288 |
| FY 2018Yearly · 2018-12-31 | Product | Service Revenues Net | 2,000 | USD | 0001493152-20-005288 |
| FY 2018Yearly · 2018-12-31 | Product | Software Revenues Net | 277,713 | USD | 0001493152-20-005288 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.